Karl Ulrich Bayer

7PUBLICATIONS
5CO-AUTHORS
Characterisation of biological macromoleculesOptical properties of materialsMemory and attentionMedical infection agents (incl. prions)Deep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 26, 2025
The CaMKII D135N mutation blocks kinase activity and reduces GluN2B binding.

Matthew E Larsen, C Madison Barker, Raul Satoshi Vargas

|Jul 09, 2025
CaMKII monomers are sufficient for GluN2B binding, co-condensation, and synaptic potentiation.

Carolyn Nicole Brown, C Madison Barker, Carley N Miller

|Mar 17, 2025
Oxygen/glucose-deprivation causes long-term impairment of synaptic CaMKII movement.

Olivia R Buonarati, Nidia Quillinan, K Ulrich Bayer

|Nov 18, 2024
A revised view of the role of CaMKII in learning and memory.

Karl Ulrich Bayer, Karl Peter Giese

|Aug 30, 2023
LTP induction by structural rather than enzymatic functions of CaMKII.

Jonathan E Tullis, Matthew E Larsen, Nicole L Rumian

|Apr 15, 2021
CaMKII holoenzyme mechanisms that govern the LTP versus LTD decision.

Sarah G Cook, Olivia R Buonarati, Steven J Coultrap

Pageof 2